Showing results (91-100 of 160) with videos related to
Sort By:
Pageof 16
Social Science & Medicine (1982)|August 1, 1997
Awareness of dying: prevalence, causes and consequencesC Seale, J Addington-Hall, M McCarthyCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1997
Placebos in clinical trials of psychotropic medicationD Addington, R Williams, Y Lapierre, et al.Palliative Medicine|March 1, 1997
The effects of the clinical characteristics of dying cancer patients on informal caregivers' satisfaction with palliative careW K Fakhoury, M McCarthy, J Addington-HallScandinavian Journal of Social Medicine|February 14, 1998
Carers' health status: is it associated with their evaluation of the quality of palliative care?W K Fakhoury, M McCarthy, J Addington-HallAddiction (Abingdon, England)|July 1, 1997
Treatment of substance abusers: single or mixed gender programs?D C Hodgins, N el-Guebaly, J AddingtonSchizophrenia Research|March 22, 2003
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sampleT J Miller, R B Zipursky, D Perkins, et al.Schizophrenia Research|March 30, 2001
Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable periodC Lançon, P Auquier, G Reine, et al.Psychiatry Research|January 26, 2000
Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression ScaleC Lançon, P Auquier, G Reine, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1989
Psychiatry training and researchK Gibson, D Addington, N Brager, et al.Acta Psychiatrica Scandinavica|March 21, 1998
Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patientsD Bernard, C Lançon, P Auquier, et al.Pageof 16